Marketing Myostatin Inhibitors with Fake Science | The Institute for Creation Research

Marketing Myostatin Inhibitors with Fake Science

Body builders and other athletes use nutritional supplements to increasingly exploit the muscular mass-building benefits of reducing the levels of a protein in the body called "myostatin." While these products may be helpful and effective, the evolutionary sales pitch used to promote these supplements is defective and unscientific.

Myostatin, also known as "growth differentiation factor 8" (GDF-8), is a protein in humans that circulates in the blood system and acts on muscle tissue by binding a receptor on the muscle-cell surface. This limits and regulates cell growth and differentiation.1 In general, the less myostatin in the blood system, the more muscle mass can be developed. Its effectiveness depends on a number of other issues and conditions.

Seeing the profit potential, nutritional supplement companies have developed and are selling products that contain natural myostatin inhibitors to help athletes increase muscle mass.1 Myostatin inhibitors may also offer therapeutic help to the elderly and muscle atrophied people suffering from various diseases.1

Scientists have learned much about how myostatin works in various animals, particularly racing dogs.2 Because animals have two sets of chromosomes, and hence two copies of every gene, geneticists can more readily study the consequences of defective genes. In greyhound dog breeds that had one good myostatin gene and one defective copy of the gene (and thus reduced myostatin levels), scientists found that these dogs were athletically superior in short 300-meter races compared to those with two good gene copies. However, the dogs with two good copies of the gene and normal myostatin levels were superior in the longer 900-meter races. The dogs with two bad copies of the gene were grossly over-muscled mutants that had virtually no athletic capability and only made novel-looking pets. These same types of effects have also been observed in other types of animals.

Because of the benefits of lowering myostatin levels for bodybuilders, one of the sales pitches claims that the myostatin genetic pathway is a vestigial evolutionary remnant—a sort of Darwinian leftover in humans that we need to correct. However, as can be clearly seen from the studies in animals, bodies need myostatin to regulate cell growth. In fact, humans who eat a healthy low-calorie and low-fat diet, along with exercising regularly, already have low myostatin levels compared to those with unhealthy lifestlyes.1

In addition to the data from animal studies, the field of functional genomics has clearly shown that the myostatin gene is involved in a wide variety of cell processes with gene expression detected in the nervous system, immune system, muscle tissue, various internal organs, secretory cells, and reproductive tissues.3 Clearly, myostatin plays a role in a wide variety of important cell processes.

Myostatin is assuredly not the evolutionary vestige touted in the marketing hype of some of the nutritional supplement vendors. Its role in regulating muscle mass has a clear purpose, such as normal development and the regulatory tradeoff with endurance. Inhibiting myostatin may provide bodybuilders with more muscle mass and strength, but it diminishes endurance.

The evolutionary spin written into myostatin inhibitor advertisements ignores good science while appealing to an imaginary evolutionary past—all in order to sell product. Myostatin and its complex functional role in the cell is evidence of divine bioengineering, not evolution.

References

  1. LeBrasseur, N. K. 2012. Building muscle, browning fat and preventing obesity by inhibiting myostatin. Diabetologia. 55 (1): 13–17. 
  2. Mosher, D. S. et al. 2007. A Mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLOS Genetics. 3 (5): 79. 
  3. Wu, C. et al. 2013. BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 41(D1): D561-565. 

* Dr. Tomkins is Research Associate at the Institute for Creation Research and received his Ph.D. in Genetics from Clemson University.

Article posted on May 17, 2013.

The Latest
NEWS
August 2025 ICR Wallpaper
"And let us not grow weary while doing good, for in due season we shall reap if we do not lose heart." (Galatians 6:9 NKJV) ICR's August...

NEWS
Quietly ''Devolving'' Tomatoes?
Apparently, evolution (and natural selection) can do almost anything: If new forms appear, the credit goes to creative natural selection; if old...

CREATION PODCAST
Five Unforgettable Lessons Learned from the Scopes Trial | The...
The Scopes Trial is one of the most famous court cases in American history, and this year marks its one hundredth anniversary....

NEWS
Yet Another Revised Age for the Land-Animal Ancestor
An allegedly vital piece of animal evolution was first discovered in 1984 in Scotland. Conventional scientists suggested the fossil of Westlothiana...

NEWS
Dr. James S. Johnson Goes Home to the Lord
Dr. James S. Johnson, chief academic officer and associate professor of apologetics for ICR’s School of Biblical Apologetics (SOBA), joined his...

NEWS
Pluto’s Largest Moon Looks Young
When the New Horizons space probe captured images of Pluto and its large moon Charon as it flew by in 2015, conventional scientists were surprised by...

NEWS
55-Million-Year-Old Tree Frog…Is Still a Tree Frog
In the 1990s, Australian paleontologists discovered fossil frog bones during a dig in Murgon, Queensland.1 This new species of frog—Litoria...

NEWS
Pastor and Longtime ICR Supporter Dr. John MacArthur Now with...
Faithful ICR supporter and pastor Dr. John MacArthur went home to be with the Lord on Monday, July 14, 2025, completing his 86-year pilgrimage.1...

CREATION PODCAST
Setting Sights on Scopes: The Truth Behind the Infamous Monkey...
The Scopes Trial is one of the most famous court cases in American history, and this year marks its one hundredth anniversary. Often,...

NEWS
Did Earthworms Rewrite Their DNA to Survive on Land?
An earthworm news story was recently posted that openly questions Darwin’s gradual and slow evolutionary progress in the living world.1...